Elevated CA19-9 in IgG4-related disease

Area of Science:

• Immunology
• Gastroenterology
• Oncology

Background:

• Immunoglobulin G4-related disease (IgG4-RD) can mimic pancreatic and hepatobiliary cancers.
• Serum carbohydrate antigen 19-9 (CA19-9) is a key marker for biliary cancer diagnosis.
• Elevated CA19-9 has been observed in patients with IgG4-RD.

Purpose of the Study:

• To investigate if serum IgG4 interferes with CA19-9 measurements.
• To determine the relationship between CA19-9 levels and IgG4-RD.
• To explore potential causes of elevated CA19-9 in IgG4-RD patients.

Main Methods:

• Quality assurance analysis of paired IgG4 and CA19-9 measurements.
• In vitro mixing studies to assess IgG4 interference with CA19-9 assays.
• Retrospective chart review comparing IgG4-RD patients with normal vs. elevated CA19-9.

Main Results:

• No association was found between serum IgG4 and CA19-9 levels in 487 individuals.
• Mixing studies confirmed no interference of high IgG4 on CA19-9 measurements.
• Among 20 IgG4-RD patients, 11 had elevated CA19-9; no significant difference in bilirubin levels was observed between groups.

Conclusions:

• Serum IgG4 does not interfere with CA19-9 measurements.
• Elevated CA19-9 in IgG4-RD is likely related to the disease process itself.
• The findings differentiate IgG4-RD from biliary obstruction in the context of elevated CA19-9.